We are live on ! Find out more
NVAX icon

Novavax

143 hedge funds and large institutions have $184M invested in Novavax in 2016 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 40 increasing their positions, 51 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

2.69% more ownership

Funds ownership: 0%2.69% (+2.7%)

14% less funds holding

Funds holding: 167143 (-24)

22% less repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 51

37% less call options, than puts

Call options by funds: $1.89M | Put options by funds: $3.02M

48% less capital invested

Capital invested by funds: $352M → $184M (-$168M)

55% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 40

Holders
143
Holders Change
-24
Holders Change %
-14.37%
% of All Funds
3.57%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
18
Increased
40
Reduced
51
Closed
40
Calls
$1.89M
Puts
$3.02M
Net Calls
-$1.12M
Net Calls Change
+$2.27M

NVAX Hedge Fund Activity: Q4 2016 in Review

143 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in Novavax (NVAX) for Q4 2016, worth a combined $184M — down 48% from $352M a quarter earlier.

Sellers outnumbered buyers: 40 funds closed out of NVAX and 18 opened new positions — a net loss of 22 holders — while 51 trimmed existing stakes and 40 added.

The largest buyer was State Street, adding an estimated $14.5M. The largest seller was Wellington Management Group, exiting entirely with an estimated $30.8M sold.

  • 143 institutional investors held Novavax (NVAX) as of Q4 2016, down from 167 in Q3 2016.
  • Funds reported $184M of Novavax stock for Q4 2016, down 48% quarter-over-quarter.
  • 18 funds opened new Novavax positions in Q4 2016 and 40 closed out, a net change of -22 holders.
  • The largest Novavax buyer in Q4 2016 was State Street, an estimated $14.5M added.
  • The largest Novavax seller in Q4 2016 was Wellington Management Group, an estimated $30.8M sold.

Based on aggregated 13F filings for Q4 2016.